Science Topics
The On-Topic Netowork

Science > Pharmacokinetic


Pharmacokinetic
Pharmacokinetic
Pharmacokinetic
Pharmacokinetic
Pharmacokinetic

The following information is about Pharmacokinetic.

Pharmacokinetic Defined

The study of absorption, distribution, metabolism and excretion of a drug

This definition is in context to Science. See more contextual defintions for Pharmacokinetic.


RegeneRx To Develop RGN-457 For Cystic Fibrosis

Published October 3, 2008, 4:07 am, Medical News Today

Regenerx Biopharmaceuticals, INC. (AMEX:RGN) announced today that it is seeking a strategic partner to assist in the development of RGN-457 for the treatment of cystic fibrosis (CF). RGN-457 is based on thymosin beta 4 (Tβ4) peptide formulated as an inhaled therapeutic agent to address this patient population.

Full Story


Aeolus Pharmaceuticals Announces Initiation Of Multiple Dose Study Of AEOL 10150 In A Patient With ALS

Published October 2, 2008, 4:07 am, Medical News Today

Aeolus Pharmaceuticals, Inc. (OTCBB: AOLS) announced today that it has initiated a follow-on Phase I open label compassionate use multiple dose study of AEOL 10150 in a patient diagnosed with progressive and debilitating amyotrophic lateral sclerosis, also referred to as ALS or Lou Gehrig's disease. The study is being conducted at UCLA by Martina Wiedau-Pazos, M.D.

Full Story


Alimera Reports Results From The Six-Month Interim Readout Of The Human PK Iluvien(TM) Study

Published October 2, 2008, 3:06 am, Medical News Today

Alimera Sciences, Inc., a privately held biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, reported the interim month six safety and efficacy results from the first human pharmacokinetic (PK) study of Iluvien(TM).

Full Story


High Growth Reported for the World Pulmonary Drug Delivery Technologies Market

Published October 1, 2008, 3:16 pm, Marketwire via Yahoo! Finance

Reportlinker.com announces that a new market research report related to the Pharmaceutical industry industry is available in its catalogue.

Full Story


RegeneRx to Develop RGN-457 for Cystic Fibrosis

Published October 1, 2008, 6:44 am, Centre Daily Times

REGENERX BIOPHARMACEUTICALS, INC. (AMEX:RGN) (www.regenerx.com) announced today that it is seeking a strategic partner to assist in the development of RGN-457 for the treatment of cystic fibrosis (CF). RGN-457 is based on thymosin beta 4 (TB4) peptide formulated as an inhaled therapeutic agent to address this patient population. CF is a life-threatening, hereditary disease that impairs the ...

Full Story


RegeneRx to Develop RGN-457 for Cystic Fibrosis

Published October 1, 2008, 6:13 am, Business Wire via Yahoo! Finance

BETHESDA, Md.----REGENERX BIOPHARMACEUTICALS, INC. announced today that it is seeking a strategic partner to assist in the development of RGN-457 for the treatment of cystic fibrosis .

Full Story


Alimera Reports Results From the Six-Month Interim Readout of the Human PK Iluvien(TM) Study

Published October 1, 2008, 5:00 am, PR Newswire via Yahoo! Finance

Alimera Sciences, Inc., a privately held biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today reported the interim month six safety and efficacy results from the first human pharmacokinetic study of Iluvien.

Full Story


Aeolus Pharmaceuticals Announces Initiation of Multiple Dose Study of AEOL 10150 in a Patient with ALS

Published September 30, 2008, 6:00 am, Business Wire via Yahoo! Finance

LAGUNA NIGUEL, Calif.----Aeolus Pharmaceuticals, Inc. announced today that it has initiated a follow-on Phase I open label compassionate use multiple dose study of AEOL 10150 in a patient diagnosed with progressive and debilitating amyotrophic lateral sclerosis, also referred to as ALS or Lou Gehrig's disease.

Full Story


Pharsight to Present On Modeling and Simulation At 'Magic Bullets' to Treat Disease World Conference

Published September 30, 2008, 3:30 am, GlobeNewswire via Yahoo! Finance

MOUNTAIN VIEW, Calif., Sept. 30, 2008 -- Pharsight Corporation , a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug development, today announced that Samer Mouksassi, Pharm.D., associate scientist, Pharsight Reporting and Analysis Services, has been invited to speak to clinical and pharmacological scientists attending the 2nd World ...

Full Story


Are you looking for additional Science > Pharmacokinetic news? Try our new "Pharmacokinetic News Focus" area.

Off-site Pharmacokinetic Links, User Submitted

The following links have been collected through user bookmark submission in the Pharmacokinetic category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Tue Jan 22

Wed Oct 24

Thu Dec 21

Sat Sep 23

Fri Dec 16

If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Pharmacokinetic. If you would like to find related tags we recommend Tag Patterns > Pharmacokinetic

Off-site Pharmacokinetic Research Links

If you still need additional information on Pharmacokinetic then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Science

If you know the Science Term Name use the links below to quickly jump to your desired focus.



Bookmark Us

The On Topic Network

This website is part of The On Topic Network.

Thank You

Science.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.

Best Viewed With

License

Creative Commons License This work is licensed under Creative Commons.




Powered by Odin Assemble 2.5a